Haensel, Daniel https://orcid.org/0000-0001-5168-4068
Daniel, Bence https://orcid.org/0000-0002-2410-8767
Gaddam, Sadhana
Pan, Cory https://orcid.org/0000-0003-1808-6239
Fabo, Tania https://orcid.org/0000-0002-8987-0672
Bjelajac, Jeremy https://orcid.org/0000-0001-7628-1652
Jussila, Anna R. https://orcid.org/0000-0002-5451-1813
Gonzalez, Fernanda
Li, Nancy Yanzhe https://orcid.org/0000-0001-6217-5234
Chen, Yun
Hou, JinChao
Patel, Tiffany
Aasi, Sumaira
Satpathy, Ansuman T. https://orcid.org/0000-0002-5167-537X
Oro, Anthony E. https://orcid.org/0000-0002-6261-138X
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (ARO54780, ARO46786, 5t32AR7422, K08CA23188)
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1F32CA254434)
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases
Article History
Received: 26 October 2022
Accepted: 7 April 2023
First Online: 10 May 2023
Competing interests
: A.T.S. is a founder of Immunai and Cartography Biosciences and receives research funding from Allogene Therapeutics and Merck Research Laboratories. The remaining authors declare no other competing interests.